Cargando…
Chemoproteomic Profiling Reveals that Anti-Cancer Natural Product Dankastatin B Covalently Targets Mitochondrial VDAC3
Chlorinated gymnastatin and dankastatin alkaloids derived from the fungal strain Gymnascella dankaliensis have been reported to possess significant anti-cancer activity but their mode of action is unknown. These members possess electrophilic functional groups that may undergo covalent bond formation...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9934694/ https://www.ncbi.nlm.nih.gov/pubmed/36798342 http://dx.doi.org/10.1101/2023.02.11.528139 |
_version_ | 1784889931025350656 |
---|---|
author | Belcher, Bridget P. Machicao, Paulo A. Tong, Binqi Ho, Emily Friedli, Julia So, Brian Bui, Helen Isobe, Yosuke Maimone, Thomas J. Nomura, Daniel K. |
author_facet | Belcher, Bridget P. Machicao, Paulo A. Tong, Binqi Ho, Emily Friedli, Julia So, Brian Bui, Helen Isobe, Yosuke Maimone, Thomas J. Nomura, Daniel K. |
author_sort | Belcher, Bridget P. |
collection | PubMed |
description | Chlorinated gymnastatin and dankastatin alkaloids derived from the fungal strain Gymnascella dankaliensis have been reported to possess significant anti-cancer activity but their mode of action is unknown. These members possess electrophilic functional groups that may undergo covalent bond formation with specific proteins to exert their biological activity. To better understand the mechanism of action of this class of natural products, we mapped the proteome-wide cysteine-reactivity of the most potent of these alkaloids, dankastatin B, using activity-based protein profiling chemoproteomic approaches. We identified a primary target of dankastatin B in breast cancer cells as cysteine C65 of the voltage-dependent anion selective channel on the outer mitochondrial membrane VDAC3. We demonstrated direct and covalent interaction of dankastatin B with VDAC3. VDAC3 knockdown conferred hyper-sensitivity to dankastatin B-mediated anti-proliferative effects in breast cancer cells indicating that VDAC3 was at least partially involved in the anti-cancer effects of this natural product. Our study reveals a potential mode of action of dankastatin B through covalent targeting of VDAC3 and highlight the utility of chemoproteomic approaches in gaining mechanistic understanding of electrophilic natural products. |
format | Online Article Text |
id | pubmed-9934694 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cold Spring Harbor Laboratory |
record_format | MEDLINE/PubMed |
spelling | pubmed-99346942023-02-17 Chemoproteomic Profiling Reveals that Anti-Cancer Natural Product Dankastatin B Covalently Targets Mitochondrial VDAC3 Belcher, Bridget P. Machicao, Paulo A. Tong, Binqi Ho, Emily Friedli, Julia So, Brian Bui, Helen Isobe, Yosuke Maimone, Thomas J. Nomura, Daniel K. bioRxiv Article Chlorinated gymnastatin and dankastatin alkaloids derived from the fungal strain Gymnascella dankaliensis have been reported to possess significant anti-cancer activity but their mode of action is unknown. These members possess electrophilic functional groups that may undergo covalent bond formation with specific proteins to exert their biological activity. To better understand the mechanism of action of this class of natural products, we mapped the proteome-wide cysteine-reactivity of the most potent of these alkaloids, dankastatin B, using activity-based protein profiling chemoproteomic approaches. We identified a primary target of dankastatin B in breast cancer cells as cysteine C65 of the voltage-dependent anion selective channel on the outer mitochondrial membrane VDAC3. We demonstrated direct and covalent interaction of dankastatin B with VDAC3. VDAC3 knockdown conferred hyper-sensitivity to dankastatin B-mediated anti-proliferative effects in breast cancer cells indicating that VDAC3 was at least partially involved in the anti-cancer effects of this natural product. Our study reveals a potential mode of action of dankastatin B through covalent targeting of VDAC3 and highlight the utility of chemoproteomic approaches in gaining mechanistic understanding of electrophilic natural products. Cold Spring Harbor Laboratory 2023-02-11 /pmc/articles/PMC9934694/ /pubmed/36798342 http://dx.doi.org/10.1101/2023.02.11.528139 Text en https://creativecommons.org/licenses/by-nc/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/) , which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator. |
spellingShingle | Article Belcher, Bridget P. Machicao, Paulo A. Tong, Binqi Ho, Emily Friedli, Julia So, Brian Bui, Helen Isobe, Yosuke Maimone, Thomas J. Nomura, Daniel K. Chemoproteomic Profiling Reveals that Anti-Cancer Natural Product Dankastatin B Covalently Targets Mitochondrial VDAC3 |
title | Chemoproteomic Profiling Reveals that Anti-Cancer Natural Product Dankastatin B Covalently Targets Mitochondrial VDAC3 |
title_full | Chemoproteomic Profiling Reveals that Anti-Cancer Natural Product Dankastatin B Covalently Targets Mitochondrial VDAC3 |
title_fullStr | Chemoproteomic Profiling Reveals that Anti-Cancer Natural Product Dankastatin B Covalently Targets Mitochondrial VDAC3 |
title_full_unstemmed | Chemoproteomic Profiling Reveals that Anti-Cancer Natural Product Dankastatin B Covalently Targets Mitochondrial VDAC3 |
title_short | Chemoproteomic Profiling Reveals that Anti-Cancer Natural Product Dankastatin B Covalently Targets Mitochondrial VDAC3 |
title_sort | chemoproteomic profiling reveals that anti-cancer natural product dankastatin b covalently targets mitochondrial vdac3 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9934694/ https://www.ncbi.nlm.nih.gov/pubmed/36798342 http://dx.doi.org/10.1101/2023.02.11.528139 |
work_keys_str_mv | AT belcherbridgetp chemoproteomicprofilingrevealsthatanticancernaturalproductdankastatinbcovalentlytargetsmitochondrialvdac3 AT machicaopauloa chemoproteomicprofilingrevealsthatanticancernaturalproductdankastatinbcovalentlytargetsmitochondrialvdac3 AT tongbinqi chemoproteomicprofilingrevealsthatanticancernaturalproductdankastatinbcovalentlytargetsmitochondrialvdac3 AT hoemily chemoproteomicprofilingrevealsthatanticancernaturalproductdankastatinbcovalentlytargetsmitochondrialvdac3 AT friedlijulia chemoproteomicprofilingrevealsthatanticancernaturalproductdankastatinbcovalentlytargetsmitochondrialvdac3 AT sobrian chemoproteomicprofilingrevealsthatanticancernaturalproductdankastatinbcovalentlytargetsmitochondrialvdac3 AT buihelen chemoproteomicprofilingrevealsthatanticancernaturalproductdankastatinbcovalentlytargetsmitochondrialvdac3 AT isobeyosuke chemoproteomicprofilingrevealsthatanticancernaturalproductdankastatinbcovalentlytargetsmitochondrialvdac3 AT maimonethomasj chemoproteomicprofilingrevealsthatanticancernaturalproductdankastatinbcovalentlytargetsmitochondrialvdac3 AT nomuradanielk chemoproteomicprofilingrevealsthatanticancernaturalproductdankastatinbcovalentlytargetsmitochondrialvdac3 |